Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to Matters Arising about the etiology of ventilator-associated pneumonia in the European POS-VAP cohort.

Critical care (London, England)·2026
Same author

Phenotypic convergence and collateral susceptibility development in Pseudomonas aeruginosa under antibiotic exposure in ICU patients.

npj antimicrobials and resistance·2026
Same author

Challenges in early detection and prognostication of sepsis: new approaches from the emergency department and intensive care unit.

EClinicalMedicine·2026
Same author

Correction: Refractory septic shock new definition: a first stone to pave a long way.

Intensive care medicine·2026
Same author

Refractory septic shock new definition: a first stone to pave a long way.

Intensive care medicine·2026
Same author

Perpetual observational study of the clinical and microbiological epidemiology of ventilator-associated pneumonia in Europe.

Critical care (London, England)·2026

Related Experiment Video

Updated: Apr 16, 2026

Substructure Analyzer: A User-Friendly Workflow for Rapid Exploration and Accurate Analysis of Cellular Bodies in Fluorescence Microscopy Images
14:28

Substructure Analyzer: A User-Friendly Workflow for Rapid Exploration and Accurate Analysis of Cellular Bodies in Fluorescence Microscopy Images

Published on: July 15, 2020

8.5K

What strategy should France implement for H2020?

Jean-François Dhainaut1, Vincent Diebolt2, Brigitte Pouletty-Lefèbvre3

  • 1DRCD, AP-HP, Hôpital Saint Louis, Paris, France - GIRCI Ile-de-France, Hôpital Saint Louis, Paris, France.

Therapie
|March 10, 2015
PubMed
Summary

France underperforms in EU research funding, receiving less than its financial contribution. Strategies are proposed to boost French participation in European clinical research projects and funding applications.

More Related Videos

Delivery of the Cas9/sgRNA Ribonucleoprotein Complex in Immortalized and Primary Cells via Virus-like Particles "Nanoblades"
09:23

Delivery of the Cas9/sgRNA Ribonucleoprotein Complex in Immortalized and Primary Cells via Virus-like Particles "Nanoblades"

Published on: March 31, 2021

5.8K
Co-culture of Glioblastoma Stem-like Cells on Patterned Neurons to Study Migration and Cellular Interactions
10:08

Co-culture of Glioblastoma Stem-like Cells on Patterned Neurons to Study Migration and Cellular Interactions

Published on: February 24, 2021

7.1K

Related Experiment Videos

Last Updated: Apr 16, 2026

Substructure Analyzer: A User-Friendly Workflow for Rapid Exploration and Accurate Analysis of Cellular Bodies in Fluorescence Microscopy Images
14:28

Substructure Analyzer: A User-Friendly Workflow for Rapid Exploration and Accurate Analysis of Cellular Bodies in Fluorescence Microscopy Images

Published on: July 15, 2020

8.5K
Delivery of the Cas9/sgRNA Ribonucleoprotein Complex in Immortalized and Primary Cells via Virus-like Particles "Nanoblades"
09:23

Delivery of the Cas9/sgRNA Ribonucleoprotein Complex in Immortalized and Primary Cells via Virus-like Particles "Nanoblades"

Published on: March 31, 2021

5.8K
Co-culture of Glioblastoma Stem-like Cells on Patterned Neurons to Study Migration and Cellular Interactions
10:08

Co-culture of Glioblastoma Stem-like Cells on Patterned Neurons to Study Migration and Cellular Interactions

Published on: February 24, 2021

7.1K

Area of Science:

  • European Union Research and Innovation Policy
  • International Scientific Collaboration
  • Clinical Research Funding

Background:

  • Horizon 2020, the EU's 8th Framework Programme, has a budget of €79 billion.
  • France's participation in previous EU Framework Programmes has not aligned with its scientific or financial contributions.
  • A notable funding shortfall of €600 million exists for French-coordinated projects.

Purpose of the Study:

  • To analyze France's participation in EU Framework Programmes.
  • To identify reasons for France's underrepresentation in European clinical research.
  • To propose strategies for enhancing French engagement in EU research initiatives.

Main Methods:

  • Analysis of French financial contributions versus funding returns in the 7th Framework Programme.
  • Comparison of French clinical research participation with neighboring countries.
  • Identification of barriers to French participation in Horizon 2020.

Main Results:

  • France contributed 16.5-17% of the 7th Framework Programme budget but received only 12.5-13% in return.
  • French participation in clinical research is lower than in comparable EU nations.
  • Barriers include resource dilution, lack of multidisciplinarity, and insufficient knowledge of Horizon 2020 mechanisms.

Conclusions:

  • France needs to improve its strategic approach to secure greater returns from EU research funding.
  • Proposed strategies include broadening scientific perspectives, valuing European collaboration, and establishing expert support centers for funding applications.